Read about Endologix
in the news

Embrace the evidence.

The Latest:

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

See Release

All News

Archives

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit

Endologix Appoints Mike Mathias as Chief Commercial Officer

Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study

Endologix Announces that Art Taylor Joins Board of Directors